(Q45374140)

13 December 2017

title

Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients (English)

1 reference

13 December 2017

1 reference

1 reference

1 reference

Yukitomo Urata

1

1 reference

13 December 2017

Ryoko Uesato

2

1 reference

13 December 2017

Dai Tanaka

3

1 reference

13 December 2017

Kenji Kowatari

4

1 reference

13 December 2017

Taisuke Nitobe

5

1 reference

13 December 2017

Yoshihide Nakamura

6

1 reference

13 December 2017

Shigeru Motomura

7

1 reference

13 December 2017

publication date

29 July 2010

1 reference

13 December 2017

1 reference

13 December 2017

volume

21

1 reference

13 December 2017

issue

1

1 reference

13 December 2017

page(s)

16-23

1 reference

Hepatitis B and hepatocellular carcinoma

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0337-Z

Reactivation of hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0337-Z

New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0337-Z

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0337-Z

Long-term histologic and virologic outcomes of acute self-limited hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0337-Z

Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0337-Z

Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0337-Z

Development of fulminant hepatitis B (precore variant mutant type) after the discontinuation of low-dose methotrexate therapy in a rheumatoid arthritis patient

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0337-Z

Hepatitis B virus reactivation during therapy with etanercept in an HBsAg-negative and anti-HBs-positive patient

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0337-Z

Hepatitis B reactivation after chemotherapy: two decades of clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0337-Z

TNF-mediated inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0337-Z

Biologic therapy for rheumatoid arthritis: clinical efficacy and predictors of response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0337-Z

Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0337-Z

Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0337-Z

Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0337-Z

Lack of tumor necrosis factor alpha induces impaired proliferation of hepatitis B virus-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0337-Z

Hepatitis B virus infection--natural history and clinical consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0337-Z

Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0337-Z

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0337-Z

Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0337-Z

Long-term anti-TNFalpha therapy for ankylosing spondylitis in two patients with chronic HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0337-Z

Interleukin 6: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0337-Z

Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0337-Z

Occult hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0337-Z

10.3109/S10165-010-0337-Z

21 January 2018

Identifiers

DOI

1 reference

release_ie6vromxpzcflourgcqudzfkga

13 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ie6vromxpzcflourgcqudzfkga

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference